Tyra Biosciences, Inc.

The number of biopharma initial public offerings in the US in 2024 grew to four with IPOs by Alto Neuroscience Inc. and Fractyl Health , showing that investors continue to be supportive of certain

The number of US initial public offerings by biopharmaceutical companies in 2021 reached 87 on 14 September when DICE Therapeutics, Inc. , Tyra Biosciences, Inc. and Pasithea Therapeutics Corp. w

Biopharmaceutical companies raised $1.5bn in 11 venture capital mega-rounds of $100m or more during the last week and a half of March. Including VC and other financings under $100m, 35 privately held